查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439497

全球冠状动脉导丝市场：洞察、竞争格局、市场预测：2030 年

Coronary Guidewires - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2024年至2030年期间，全球冠状动脉导引线市场规模将以5.7%的复合年增长率扩大。对冠状动脉导引线的需求主要是由全球冠状动脉疾病（CAD）盛行率上升所推动的。此外，先进和创新技术的不断采用、微创心臟手术意识的不断增强、易患各种心血管疾病的老年人口不断增加，以及导致冠心病的各种危险因素的数值不断上升。市场的成长、产品上市和批准的增加等正在促进2024-2030 年预测期内冠状动脉导丝市场的整体成长。

由于多种因素，冠状动脉导引线市场的产品需求正在急剧增长，但主要因素之一是全球冠状动脉绕道手术（CABG）病例数量的不断增加。例如，根据经济合作暨发展组织（OECD）2023年的数据，2021年土耳其CABG病例数为45,290例，德国为38,859例。

CABG 是一种用于治疗冠状动脉疾病的外科手术。血液从主动脉狭窄或阻塞的区域转移，以改善心臟的血流和氧气供应。在此过程中，使用冠状动脉导线将治疗药物输送到冠状动脉系统的患病区域。因此，随着CABG病例数的增加，对冠状动脉导引线的需求也将增加，导致预测期内整体冠状动脉导线市场的扩大。

该报告研究了全球冠状动脉导丝市场，并提供了市场概述，包括按材料、最终用户、地区和参与市场的公司概况划分的趋势。

目录

第一章 冠脉导丝市场报告简介

第二章冠脉导丝市场概要

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章冠脉导丝市场主要因素分析

  • 冠状动脉导线市场驱动因素
  • 冠脉导丝市场限制因素及挑战
  • 冠状动脉导线市场机会

第五章冠脉导丝市场波特五力分析

第六章 冠状动脉导丝市场概况

  • 按材质
  • 按最终用户
  • 按地区

第七章冠状动脉导线市场公司与产品概况

  • Medtronic
  • Boston Scientific Corporation
  • Integer Holdings Corporation
  • Abbott
  • Teleflex Incorporated
  • ASAHI INTECC CO., LTD.
  • Koninklijke Philips N.V
  • SCW Medicath Ltd
  • Shanghai Kindly Medical Instruments Co., Ltd.
  • Terumo Medical Corporation
  • Shenzhen MicroApproach Medical Technology CO., LTD.
  • SP Medical
  • Rontis Corporation
  • Balton Sp. z o. o
  • B. Braun SE

第8章 KOL观点

第9章 专案方法

第10章 关于 DelveInsight

第11章 免责声明与联络我们

Product Code: DIMDCL0315

The Coronary Guidewire Market By Material (Nitinol, Stainless Steel, And Others), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of coronary heart disease and and the rising cases of coronary artery bypass graft surgeries across the globe

The global coronary guidewire market is estimated to grow at a CAGR of 5.7% during the forecast period from 2024 to 2030. The demand for coronary guidewire is primarily being boosted due to the increasing prevalence of coronary artery disease (CAD) across the globe. Further, the rising adoption of advanced and innovative technologies, the rising awareness about minimally invasive heart surgeries, the increasing geriatric population prone to various cardiovascular diseases, rising figures of various risk factors causing coronary heart diseases, and the increasing product launches and approval among others, are thereby contributing to the overall growth of the coronary guidewire market during the forecast period from 2024-2030.

Coronary Guidewire Market Dynamics:

The coronary guidewire market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increasing cases of coronary artery bypass graft (CABG) across the globe. For instance, according to the Organization for Economic Co-operation and Development (OECD) 2023, in 2021 cases of CABG were 45,290 in Turkiye and 38,859 in Germany.

A CABG is a surgical procedure used to treat coronary heart disease. It diverts blood around narrowed or clogged parts of the major arteries to improve blood flow and oxygen supply to the heart. Coronary guidewires are used in this surgery to deliver therapies to diseased areas of the coronary arterial system. Therefore, more the cases of CABG, the more the demand for the coronary guidewire, thereby increasing the overall market for coronary guidewires during the forecast period.

Furthermore, over time, high blood sugar can damage blood vessels and the nerves which control the heart. According to the Centers for Disease and Prevention Control (CDC) 2022, if a person has diabetes, he or she is twice likely to have heart disease or a stroke than someone who doesn't have diabetes. Additionally, according to IDF Diabetes Atlas Tenth Edition 2021, in 2021 approximately 537 million adults worldwide (20-79 years) were living with diabetes, and the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. From the same source, more than 1.2 million children and adolescents (0-19 years) were living with diabetes, in 2021, globally.

Thus, diabetes may cause damage to blood vessels, hypertension, and others, which can lead to heart disease or stroke. A person suffering from any heart disease may need an angioplasty, in which a catheter is inserted into vessels, using a coronary guidewire that is used to guide the catheter into place during central venous catheter (CVC) insertions, a process done in angioplasty. The purpose of a guidewire is to gain access to the blood vessels using a minimally invasive technique. Thus, the increasing cases of diabetes will increase the figures of people suffering from coronary heart diseases, thereby increasing the demand for coronary guidewires, ultimately propelling the overall market growth.

Therefore, the above-mentioned factors are contributing to the growth of the coronary guidewire market during the forecast period from 2024-2030.

However, the complications related to the coronary guidewire and others may restrict the coronary guidewire market growth during the forecast period.

Coronary Guidewire Market Segment Analysis:

Coronary guidewire market by Material (Nitinol, Stainless Steel, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the material segment of the coronary guidewire market, the stainless steel category is expected to amass a significant revenue share in the year 2023. This may be ascribed to the advantages offered by the stainless steel material.

The advantages of the stainless steel category over other material is that stainless steel is non-magnetic, non-staining, corrosion-resistant, and possess antibacterial properties. Stainless steel is easier to torque and is more rigid, providing better columnar support. All such advantages offered by the segment are responsible for their increased preference among the end-users.

Furthermore, device launches and approval, rising research & developmental activities among others will also increase the demand for coronary guidewire during the forecast period. For instance, in November 2021, FDA approved ASAHI CONFIANZA PRO 8-20 guidewire by Asahi Intecc Co., Ltd, The guide wire is constructed from a stainless-steel core wire with a platinum-nickel coil.

Therefore, the advantages offered by the stainless steel category, along with increasing device launches and approval among others will increase the demand for the stainless steel coronary guidewire market during the forecast period, thereby responsible for propelling the demand for coronary guidewires during the upcoming years.

North America is expected to dominate the overall Coronary Guidewire Market:

Among all the regions, North America is estimated to account for the largest share of the coronary guidewire market in the year 2023. Owing to the significance of key growth factors such as the increasing cases of coronary artery disease (CAD), the rising cases of angioplasty, and others in the region, are driving the North American coronary guidewire market is expected to witness positive growth in the forecast period. Furthermore, high disposable income, sophisticated healthcare infrastructure, rising approvals for new devices, and surging awareness about minimally invasive heart surgery will also help the market growth in this region.

CAD is caused by plaque build-up in the wall of the arteries that supply blood to the heart which can lead to serious medical conditions such as heart attack, heart failure, and others. To prevent this serious medical condition patient may need to go through a minimally invasive surgery called angioplasty. During the procedure, a cardiologist threads a balloon-tipped catheter to the site of the narrowed or blocked artery and then inflates the balloon to open the vessel. In such complex procedures, the use of guide wires is a must, which permits multiple recrossings of a dilated segment and allows safe serial passage of different-sized balloon catheters.

According to the Center for Disease Control and Prevention 2022, about 20.1 million adults age 20 and older had CAD, in 2020. In 2020, about 2 in 10 deaths from CAD happen in adults less than 65 years old. Thus, to maintain the mortality rate due to CAD, angioplasty at an appropriate time is required. Henceforth, the increasing cases of CAD may increase the cases of angioplasty which will ultimately increase the demand for coronary guidewires in the regional market.

Furthermore, growing preference for cardiovascular procedures such as transcatheter aortic valve replacement (TAVR), replacement, coronary artery bypass graft (CABG), angioplasty, and others to be conducted in a minimally invasive manner utilizing guidewires to transverse in the vascular system and access the desired position for catheter insertion is also crucial for raising the demand of coronary guidewires, thereby, positively impacting the overall coronary guidewire market during the forecast period.

Consequently, the aforementioned factors will increase the demand for a coronary guidewire, thereby driving the North American coronary guidewire market forward during the forecast period.

Coronary Guidewire Market Key Players:

Some of the key market players operating in the coronary guidewire market include Medtronic, Boston Scientific Corporation, Integer Holdings Corporation, Abbott, Teleflex Incorporated, ASAHI INTECC CO., LTD., Koninklijke Philips N.V, SCW Medicath Ltd., Shanghai Kindly Medical Instruments Co., Ltd., Terumo Medical Corporation, Shenzhen MicroApproach Medical Technology CO., LTD., SP Medical, Rontis Corporation, B. Braun SE, Balton Sp. z o. o., and others.

Recent Developmental Activities in the Coronary Guidewire Market:

In April 2022, Boston Scientific Corporation launched its new Kinetix Guidewire for coronary intervention (PCI) procedures.

In February 2022, Teleflex received FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI (Chronic Total Occlusion Percutaneous Coronary Intervention) procedure. CTO PCI is an alternative to heart bypass surgery, the procedure is done in a cardiac catheterization laboratory through small incisions in the leg or arm.

Key Takeaways from the Coronary Guidewire Market Report Study

Market size analysis for current coronary guidewire market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the coronary guidewire market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global coronary guidewire market.

Various opportunities are available for the other competitor in the coronary guidewire market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current coronary guidewire market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for coronary guidewire market growth in the coming future?

Target Audience who can be benefited from this Coronary Guidewire Market Report Study

Coronary guidewire products providers

Research organizations and consulting companies

Coronary guidewire-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in coronary guidewire

Various End-users who want to know more about the coronary guidewire market and the latest technological developments in the coronary guidewire market

Frequently Asked Questions for the Coronary Guidewire Market:

1. What is a coronary guidewire device?

Coronary guide wires are specialized pieces of equipment used to deliver therapies to diseased areas of the coronary arterial system. These devices are designed to navigate vessels to reach a lesion or vessel segment. Once the tip of the device arrives at its destination, it acts as a guide that larger catheters can rapidly follow for easier delivery to the treatment site.

2. What is the market for global coronary guidewire?

The global coronary guidewire market is estimated to grow at a CAGR of 5.7% during the forecast period from 2024 to 2030.

3. What are the drivers for the global coronary guidewire market?

The demand for coronary guidewire is being heightened by the increasing prevalence of coronary artery disease and other cardiovascular diseases, rising cases of angioplasty, increasing figures of coronary artery bypass graft (CABG), and others. In addition, the increasing demand for minimally invasive surgery, the increasing device launches, and approvals among others are thereby contributing to the overall growth of the coronary guidewire market during the forecast period from 2024-2030.

4. Who are the key players operating in the global coronary guidewire market?

Some of the key market players operating in the coronary guidewire market include Medtronic, Boston Scientific Corporation, Integer Holdings Corporation, Abbott, Teleflex Incorporated, ASAHI INTECC CO., LTD., Koninklijke Philips N.V, SCW Medicath Ltd., Shanghai Kindly Medical Instruments Co., Ltd., Terumo Medical Corporation, Shenzhen MicroApproach Medical Technology CO., LTD., SP Medical, Rontis Corporation, B. Braun SE, Balton Sp. z o. o., and others.

5. Which region has the highest share in the coronary guidewire market?

North America is expected to dominate the overall coronary guidewire market during the forecast period from 2024-2030. Factors such as the rising geriatric population, the rising cases of obesity, the increasing coronary diseases, and others will propel the demand for coronary guidewire in North America. Furthermore, increasing technological advancement, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about minimally invasive therapy will also help the market growth in this region.

Table of Contents

1.Coronary Guidewire Market Report Introduction

2. Coronary Guidewire Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Coronary Guidewire Market Key Factors Analysis

  • 4.1. Coronary Guidewire Market Drivers
    • 4.1.1. Increasing prevalence of coronary diseases
    • 4.1.2. Rising number of obesity, hypertension, and other risk factors
    • 4.1.3. Growing preference for minimally invasive cardiovascular surgical procedures
  • 4.2. Coronary Guidewire Market Restraints and Challenges
    • 4.2.1. Complications related to coronary guidewire
  • 4.3. Coronary Guidewire Market Opportunities
    • 4.3.1. Improvements in guidewire design and material

5. Coronary Guidewire Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. The threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Coronary Guidewire Market Layout

  • 6.1. By Material
    • 6.1.1. Nitinol
    • 6.1.2. Stainless steel
    • 6.1.3. Others
  • 6.2. By End-User
    • 6.2.1. Hospitals
    • 6.2.2. Ambulatory surgical centers
    • 6.2.3. Others
  • 6.3. By Geography
    • 6.3.1. North America
      • 6.3.1.1. The United States Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.1.2. Canada Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.1.3. Mexico Coronary Guidewire Market Size in USD Million (2021-2030)
    • 6.3.2. Europe
      • 6.3.2.1. France Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.2.2. Germany Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.2.3. United Kingdom Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.2.4. Italy Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.2.5. Spain Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.2.6. Rest of Europe Coronary Guidewire Market Size in USD Million (2021-2030)
    • 6.3.3. Asia-Pacific
      • 6.3.3.1. China Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.3.2. Japan Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.3.3. India Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.3.4. Australia Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.3.5. South Korea Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.3.6. Rest of Asia-Pacific Coronary Guidewire Market Size in USD Million (2021-2030)
    • 6.3.4. Rest of the World (RoW)
      • 6.3.4.1. Middle East Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.4.2. Africa Coronary Guidewire Market Size in USD Million (2021-2030)
      • 6.3.4.3. South America Coronary Guidewire Market Size in USD Million (2021-2030)

7. Coronary Guidewire Market Company and Product Profiles

  • 7.1. Medtronic
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Boston Scientific Corporation
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Integer Holdings Corporation
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Abbott
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Teleflex Incorporated
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. ASAHI INTECC CO., LTD.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Koninklijke Philips N.V
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. SCW Medicath Ltd
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Shanghai Kindly Medical Instruments Co., Ltd.
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Terumo Medical Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Shenzhen MicroApproach Medical Technology CO., LTD.
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. SP Medical
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Rontis Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Balton Sp. z o. o
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. B. Braun SE
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Coronary Guidewire Market in Global (2021-2030)
  • Table 3: Coronary Guidewire Market in Global by Material (2021-2030)
  • Table 4: Coronary Guidewire Market in Global by End-User (2021-2030)
  • Table 5: Coronary Guidewire Market in Global by Geography (2021-2030)
  • Table 6: Coronary Guidewire Market in North America (2021-2030)
  • Table 7: Coronary Guidewire Market in the US (2021-2030)
  • Table 8: Coronary Guidewire Market in Canada (2021-2030)
  • Table 9: Coronary Guidewire Market in Mexico (2021-2030)
  • Table 10: Coronary Guidewire Market in Europe (2021-2030)
  • Table 11: Coronary Guidewire Market in France (2021-2030)
  • Table 12: Coronary Guidewire Market in Germany (2021-2030)
  • Table 13: Coronary Guidewire Market in the United Kingdom (2021-2030)
  • Table 14: Coronary Guidewire Market in Italy (2021-2030)
  • Table 15: Coronary Guidewire Market in Spain (2021-2030)
  • Table 16: Coronary Guidewire Market in the Rest of Europe (2021-2030)
  • Table 17: Coronary Guidewire Market in Asia-Pacific (2021-2030)
  • Table 18: Coronary Guidewire Market in China (2021-2030)
  • Table 19: Coronary Guidewire Market in Japan (2021-2030)
  • Table 20: Coronary Guidewire Market in India (2021-2030)
  • Table 21: Coronary Guidewire Market in Australia (2021-2030)
  • Table 22: Coronary Guidewire Market in South Korea (2021-2030)
  • Table 23: Coronary Guidewire Market in Rest of Asia-Pacific (2021-2030)
  • Table 24: Coronary Guidewire Market in the Rest of the World (2021-2030)
  • Table 25: Coronary Guidewire Market in the Middle East (2021-2030)
  • Table 26: Coronary Guidewire Market in Africa (2021-2030)
  • Table 27: Coronary Guidewire Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Coronary Guidewire Market in Global (2021-2030)
  • Figure 3: Coronary Guidewire Market in Global by Material (2021-2030)
  • Figure 4: Coronary Guidewire Market in Global by End-User (2021-2030)
  • Figure 5: Coronary Guidewire Market in Global by Geography (2021-2030)
  • Figure 6: Coronary Guidewire Market in North America (2021-2030)
  • Figure 7: Coronary Guidewire Market in the US (2021-2030)
  • Figure 8: Coronary Guidewire Market in Canada (2021-2030)
  • Figure 9: Coronary Guidewire Market in Mexico (2021-2030)
  • Figure 10: Coronary Guidewire Market in Europe (2021-2030)
  • Figure 11: Coronary Guidewire Market in France (2021-2030)
  • Figure 12: Coronary Guidewire Market in Germany (2021-2030)
  • Figure 13: Coronary Guidewire Market in the United Kingdom (2021-2030)
  • Figure 14: Coronary Guidewire Market in Italy (2021-2030)
  • Figure 15: Coronary Guidewire Market in Spain (2021-2030)
  • Figure 16: Coronary Guidewire Market in the Rest of Europe (2021-2030)
  • Figure 17: Coronary Guidewire Market in Asia-Pacific (2021-2030)
  • Figure 18: Coronary Guidewire Market in China (2021-2030)
  • Figure 19: Coronary Guidewire Market in Japan (2021-2030)
  • Figure 20: Coronary Guidewire Market in India (2021-2030)
  • Figure 21: Coronary Guidewire Market in Australia (2021-2030)
  • Figure 22: Coronary Guidewire Market in South Korea (2021-2030)
  • Figure 23: Coronary Guidewire Market in Rest of Asia-Pacific (2021-2030)
  • Figure 24: Coronary Guidewire Market in the Rest of the World (2021-2030)
  • Figure 25: Coronary Guidewire Market in the Middle East (2021-2030)
  • Figure 26: Coronary Guidewire Market in Africa (2021-2030)
  • Figure 27: Coronary Guidewire Market in South America (2021-2030)
  • Figure 28: Market Drivers
  • Figure 29: Market Barriers
  • Figure 30: Marker Opportunities
  • Figure 31: PORTER'S Five Force Analysis